A carregar...
Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital(®) Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study
PURPOSE: The primary objective was to compare the efficacy of 12 weeks of daily treatment with Aqueous Hypromellose-based vaginal (Vagivital(®)) gel versus Aqueous Hypromellose-based vaginal gel plus 400 IU oxytocin gel in reducing the severity of the most bothersome vulvovaginal atrophy symptoms (M...
Na minha lista:
| Publicado no: | Med Devices (Auckl) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547122/ https://ncbi.nlm.nih.gov/pubmed/33116956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/MDER.S265824 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|